PATH stock forecast, quote, news & analysis
UiPath Inc offers an end-to-end cross-application enterprise automation platform principally with computer vision technology and user interface automations in its initial RPA offering, which remains the foundation of the platform... Show more
Why UiPath (PATH) Stock Is Down -34% in the Last 30 Days
Key Takeaways
- UiPath shares declined roughly 34% over the trailing 30 days, from a closing price of $18.67 on August 31 to $12.32 as of the September 29 close.
- The selloff began after the company's fiscal Q2 2027 results on September 3, which topped revenue estimates but guided to a notable slowdown in third-quarter growth.
- A series of analyst downgrades and price-target cuts followed the earnings report and a September 22 investor day, reinforcing negative sentiment.
- Despite the recent drop, the stock remains up about 13% over the trailing three months, reflecting a sharp July–August rally that has since largely unwound.
- Competition from AI-native platforms and customer pushback on UiPath's AI pricing remain key overhangs on the stock.
UiPath (PATH) Company Overview and Market Position
UiPath, Inc. is an enterprise automation and AI software company best known for pioneering robotic process automation (RPA). The company's platform combines deterministic automation with AI-powered agentic capabilities, letting organizations orchestrate workflows across business functions such as finance, customer service, healthcare, and supply chain operations. Its product portfolio includes automation tools, the UiPath Platform, and newer AI-oriented offerings aimed at helping enterprises manage increasingly complex, AI-driven processes.
Founded and led by Chief Executive Officer Daniel Dines, UiPath competes in a fast-changing market where large software vendors such as Microsoft, Salesforce, and ServiceNow are embedding their own AI agents into existing products. Investors follow PATH closely because of its role in the broader AI-automation theme, its recurring-revenue model, and the debate over how much value an independent orchestration layer can capture as AI becomes more widely distributed.
UiPath (PATH) Stock Price Performance: Last 30 Days vs. Quarter
Over the trailing 30 days, PATH fell approximately 34%, dropping from a closing price of $18.67 on August 31 to $12.32 at the September 29 close. The decline was concentrated in early September, when the stock plunged about 16.6% in a single session following its earnings release, and extended through late September after a widely watched investor day failed to provide new financial targets.
The broader quarterly picture tells a different story. Three months earlier, on June 30, the stock closed at $10.87. That means PATH is still up roughly 13% over the trailing quarter, even after the recent selloff. The quarter was marked by a powerful rally through July and August—driven by enthusiasm around AI-driven enterprise software and a stronger-than-expected fiscal Q1 report—before September's sharp reversal erased most of those gains.
What Drove PATH Stock Price in the Last 30 Days
The primary catalyst was UiPath's fiscal Q2 2027 earnings report, released after the market close on September 3. The company reported revenue of $410.3 million, up 13.4% year over year and above consensus estimates of roughly $398 million, with non-GAAP earnings per share of $0.15 in line with expectations. Annual recurring revenue (ARR) rose about 12% to $1.94 billion.
Despite the headline beat, investors focused on the guidance. UiPath's third-quarter revenue outlook of $440 million to $445 million implied a deceleration to roughly 8% year-over-year growth, down from 13.4% in Q2. Billings also came in slightly below expectations, and management pointed to longer customer decision-making cycles as enterprises weigh deterministic versus AI-driven automation. The stock dropped about 16.6% the following trading day.
Selling pressure continued as analysts reassessed the shares. Canaccord Genuity downgraded PATH to Hold, while other firms—including UBS, Barclays, RBC, Truist, and BMO—trimmed price targets. After the September 22 investor day, where management outlined an AI orchestration vision but did not provide formal fiscal 2028 guidance, additional target cuts and a downgrade to Underperform from DA Davidson further weighed on the stock. Concerns about competition and pricing pressure on UiPath's AI offerings compounded the decline.
What Drove PATH Stock Performance Over the Last Quarter
UiPath's quarterly performance was defined by two opposing forces. In July and August, the stock rallied sharply—roughly doubling from its late-June levels to a peak near $18.67 in late August—as investors rotated into AI-linked enterprise software and responded positively to the company's fiscal Q1 2027 results and an improving profitability trajectory. Management's commentary on AI-driven demand and enterprise adoption helped fuel the advance.
That momentum reversed in September. The fiscal Q2 report, despite beating on revenue, signaled slowing growth, and a wave of cautious analyst notes shifted sentiment. The broader narrative turned toward questions about whether UiPath can sustain growth as large platform vendors integrate AI agents natively and as customers push back on the company's AI pricing. The result was a stock that ended the quarter up modestly but well below its August highs.
Trending AI Robots
Tickeron's Trending AI Robots page highlights a curated selection of AI-powered trading bots. Tickeron offers hundreds of automated trading bots that monitor thousands of tickers, but only the top-performing and most relevant bots are featured in this section, helping traders focus on strategies with demonstrated traction. The bots vary widely in trading strategy, timeframe, and performance metrics, so traders can evaluate options that align with their own goals and risk tolerance. For those interested in systematic approaches to the markets, exploring the Trending AI Robots page offers a practical starting point.
PATH Stock Forecast Drivers: What Investors Should Watch Next
Investors will be watching whether UiPath can reaccelerate ARR growth and demonstrate that its AI orchestration strategy translates into durable revenue expansion. The next earnings report, expected in December, will be a key test of management's ability to execute against its full-year guidance while managing a CFO transition that elevated Hitesh Ramani to the role.
Beyond earnings, the competitive landscape remains central. The pace at which major software vendors embed AI agents, customer adoption of UiPath's newer AI products, and the company's ability to defend pricing will shape sentiment. Macroeconomic conditions—particularly interest rates and enterprise software spending trends—will also influence the stock's valuation, given its sensitivity to shifts in growth expectations. These factors, rather than any single data point, are likely to determine PATH's direction in the months ahead.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
PATH in downward trend: price dove below 50-day moving average on September 15, 2026
PATH moved below its 50-day moving average on September 15, 2026 date and that indicates a change from an upward trend to a downward trend. In 39 of 46 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 85%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on September 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PATH as a result. In 60 of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 72%.
The Moving Average Convergence Divergence Histogram (MACD) for PATH turned negative on September 04, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 32 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 74%.
The 10-day moving average for PATH crossed bearishly below the 50-day moving average on September 18, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 72%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PATH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where PATH's RSI Indicator exited the oversold zone, 25 of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 51 of 68 cases where PATH's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 75%.
The 50-day moving average for PATH moved above the 200-day moving average on August 26, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +8.12% 3-day Advance, the price is estimated to grow further. Considering data from situations where PATH advanced for three days, in 238 of 301 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
PATH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 127 of 163 cases where PATH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 78%.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 37 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.261) is normal, around the industry mean (18.522). P/E Ratio (18.194) is within average values for comparable stocks, (158.311). Projected Growth (PEG Ratio) (0.447) is also within normal values, averaging (3.648). Dividend Yield (0.000) settles around the average of (0.004) among similar stocks. P/S Ratio (4.248) is also within normal values, averaging (104.490).
The Tickeron SMR rating for this company is 46 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating fairly steady price growth. PATH’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PATH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry ComputerCommunications